Abstract
Abstract
Objective
High levels of d-dimer, a marker of thrombotic events, are associated with poor outcomes in patients with various cardiovascular diseases. However, there has been no research on its prognostic implications in acute severe hypertension. This study investigated the association between d-dimer levels and long-term mortality in patients with severe acute hypertension who visited the emergency department.
Design and method
This observational study included patients with acute severe hypertension who visited the emergency department between 2016 and 2019. Acute severe hypertension was defined as a systolic blood pressure ≥ 180 mmHg or a diastolic blood pressure ≥ 100 mmHg. Among the 10,219 patients, 4,127 who underwent d-dimer assay were analyzed. The patients were categorized into tertiles based on their d-dimer levels at the time of emergency department admission.
Results
Among the 4,127 patients with acute severe hypertension, 3.1% in the first (lowest) tertile, 17.0% in the second tertile, and 43.2% in the third (highest) tertile died within 3 years. After the adjustment for confounding variables, the third tertile of the d-dimer group (hazard ratio, 6.440; 95% confidence interval, 4.628–8.961) and the second tertile of the d-dimer group (hazard ratio, 2.847; 95% confidence interval, 2.037–3.978) had a significantly higher risk of all-cause mortality over 3 years than the first tertile of the d-dimer group.
Conclusions
d-dimer may be a useful marker for identifying the risk of mortality among patients with acute severe hypertension who visit the emergency department.
Funder
Korean Society of Hypertension
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference31 articles.
1. Peixoto AJ. Acute severe hypertension. New Engl J Med. 2019;381(19):1843–52.
2. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-115.
3. van den Born B-JH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2018;5(1):37–46.
4. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.
5. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–104.